Leading into Budget week in Canberra this week, was a journey in planning, months in advance by member based groups, to advocate for new policy and funding changes in the Australian Health System.
Some paths are taken because of new crises to be addressed in the workforce, others in considering new models of care to treat patients, or simply to get new medications onto the PBS.
Australian Health Journal met with a number of industry heads after the budget on their journeys so far in lobbying for change, their achievements, some of the disappointments and their thoughts on the road ahead, with an election round the corner.
Skip ahead:
00:35 Tegan Carrison, Executive Director Australian Association of Psychologists Inc (AAPi)
03:12 John Bruning, CEO Australasian College of Paramedicine (ACP)
09:09 Paul Sadler, CEO Aged and Community Services Australia (ACSA)
12:06 Karen Booth, President Australian Primary Health Care Association (APNA)
19:45 Jo Armstrong, CEO Cystic Fibrosis Australia
23:25 Elizabeth de Somer, CEO Medicines Australia
-
ARCS Australia
ARCS Australia Ltd is a national, membership-based organisation focused on the development and growth of the healthcare sector. ARCS provides education, career pathways, professional development and advocacy to the healthcare sector.
Our membership is made up of individuals working in regulatory affairs, clinical research, health economics, medical information and other disciplines who work in the development and quality use of therapeutic goods. ARCS members are based in industry, academia, medical research institutes, government, hospitals and patient groups.
Through its members ARCS has a broad and effective reach throughout the healthcare sector, and provides a neutral forum to develop, agree and implement aligned policies and initiatives.ARCS and its members are dedicated to improving the quality of life of healthcare consumers.
MEDIA PARTNER SINCE 2018
-
-
Consumer Commission Report – What consumer-centred health and social care should look like
ANDHealth CEO Bronwyn Le Grice steps us through key report data from 317 emerging high growth potential digital health companies across Australia. Each of these companies has been supported in some way by ANDHealth since 2017.
-
Stronger patient involvement in new medicines
New strategic agreement between Medicines Industry and Government means stronger patient involvement in new medicines.
Medicines Australia has secured a 5-year Strategic Agreement with the Federal Government, centered on earlier patient involvement and influence in the availability of new medicines in Australia.
